Congratulations to Ian Guldner, PhD who will be starting his lab at the Salk Institute in 2027! Dr. Guldner's research lies at the intersection of proteostasis, immune surveillance, and neurodegeneration (Guldner et al., Nature (2026)). Read the official announcement here.